KFDA approves two homegrown drugs

Demonstrating the strength of the country's R&D capabilities, the Korea Food and Drug Administration Wednesday approved two Korean drugs – Shinpoong Pharmaceutical’s anti-malarial drug ‘Pyramax’ and JW Pharmaceutical’s Zepid (avanafil) for treatment of erectile dysfunction (ED).

Thus Korea becomes a country to develop 17 new drugs and the two products may generate significant sales unlike ot...